Hear from Paul Biondi, President of Pioneering Medicines and Executive Partner, Flagship Pioneering, and Uli Stilz, Vice President, Novo Nordisk Bio Innovation Hub, on a new partnership bringing together Flagship’s ecosystem of first-in-category bioplatforms with the disease expertise of Novo Nordisk, to jointly create a portfolio of transformational medicines.
More from:
Human Health
Pioneering Partnerships: Advancing a Portfolio of Novel Medicines and Vaccines with GSK
Pioneering Partnerships: Accelerating our Collaboration with Pfizer
Unlocking Therapeutic Breakthroughs with the Power of Platform Technologies
Halting the Trajectory of Disease with Preemptive Health
AI in Action
